DOJ Antitrust Update Generates Uncertainty Surrounding Information Sharing And Transactions In The Healthcare Industry

The Department of Justice’s Antitrust Division rescinded three “outdated” policy statements on antitrust enforcement in healthcare, and it is expected that the Federal Trade Commission (FTC) will take similar action 

This announcement is significant for firms in the healthcare and other sectors that rely on benchmarking and other types of information exchanges that could soon be under heightened antitrust scrutiny 

The announcement is also expected to affect how the division and FTC view transactions in the healthcare industry

Please read more on